Non-Invasive Testing Device for Anaemia
NCT07361380 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 300
Last updated 2026-01-27
Summary
Anaemia (iron deficiency) arises from a reduction in the number of healthy red blood cells or the level of haemoglobin (Hb) (a protein inside red blood cells) necessary to effectively transport oxygen throughout the body. Anaemia is common among pregnant women. The gold standard for anaemia diagnosis still relies on laboratory blood tests, which come with limitations in terms of point-of-care capability, accessibility and quality. The investigators have developed a portable and user-friendly device capable of detecting anaemia rapidly and non-invasively and facilitating appropriate treatment by distinguishing anaemia due to iron deficiency from other causes. The device, named The Vascular Imaging Tool for the Auricle (VITA), utilises high-resolution imaging technology to capture detailed images of blood cells and small blood vessels within the human body. The objectives of this study are to assess VITA's performance of (haemoglobin (Hb)) testing and its ability to identify iron deficiency anaemia against the clinical gold standard of laboratory blood tests.
Conditions
- Pregnancy
Sponsors & Collaborators
-
University of Oxford
lead OTHER
Eligibility
- Min Age
- 16 Years
- Max Age
- 50 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-10-28
- Primary Completion
- 2026-04-30
- Completion
- 2026-10-01
Countries
- United Kingdom
Study Locations
More Related Trials
-
Intravenous Iron Versus Oral Iron for the Treatment of Iron Deficiency Anemia
NCT06366698 ·Status: RECRUITING ·Phase: PHASE3
-
Validation of a Smartphone App for Anemia Screening Among General Population
NCT05490823 ·Status: UNKNOWN ·Phase: NA
-
Erythropoietin Resistance in Anemia of Chronic Kidney Disease
NCT00526747 ·Status: COMPLETED
-
Treatment Response in Dialysis Anaemia
NCT02707757 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Assess Disability in Anemic Elderly Patients With Kidney Disease Receiving PROCRIT (Epoetin Alfa)
NCT00338468 ·Status: TERMINATED ·Phase: PHASE4
-
Phase III Study of GSK1278863 in Japanese Non-dialysis (ND) and Peritoneal Dialysis (PD) Subjects With Renal Anemia
NCT02791763 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Evaluate Efficacy and Safety of BGE-117 in the Treatment of Anemia of Aging
NCT04815603 ·Status: WITHDRAWN ·Phase: PHASE2
-
Comparison of Safety and Efficacy of Intravenous Iron Versus Oral Iron in Chronic Renal Failure Subjects With Anemia
NCT00236977 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of MK2578 in Patients With Chronic Kidney Disease Who Are Not on Dialysis (2578-002)
NCT00968617 ·Status: TERMINATED ·Phase: PHASE2
-
Erythropoietin Alfa in Elderly Subjects With Unexplained Anemia
NCT00954486 ·Status: WITHDRAWN ·Phase: NA
-
Spot-Check Noninvasive Hemoglobin (SpHb) Clinical Validation
NCT02930850 ·Status: COMPLETED ·Phase: NA
-
Safety & Efficacy of EPO-018B for the Treatment of Anemia in Participants With Chronic Kidney Diseases Not on Dialysis
NCT02403362 ·Status: UNKNOWN ·Phase: PHASE2
-
Pronto for Patient Blood Management
NCT03586141 ·Status: COMPLETED ·Phase: NA
-
Erythropoietin and Iron Supplementation for Patients With Chemotherapy-induced Anaemia
NCT02731378 ·Status: UNKNOWN ·Phase: PHASE4
-
Comparison of Oral Iron With IV Iron in Patients With Anemia of Chronic Renal Failure Not on Dialysis
NCT00236964 ·Status: COMPLETED ·Phase: PHASE3
-
Treatment Program for Anemia in AIDS Patients
NCT00002022 ·Status: COMPLETED ·Phase: NA
-
Safety, Tolerability, PK and PD of ADX-038 in Healthy Participants and Paroxysmal Nocturnal Hemoglobinuria (PNH) Patients
NCT05876312 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Effect of Erythropoiesis-Stimulating Agent Therapy in Patients Receiving Palliative Care of Chronic Kidney Disease
NCT03427801 ·Status: COMPLETED
-
An Open-label Trial to Determine Increased Red Blood Cell Production in Subjects With Anemia of Chronic Disease
NCT01846689 ·Status: UNKNOWN ·Phase: PHASE3
-
Study of the Efficacy and Safety of Ferrlecit in the Maintenance Dosing in Hemodialysis Patients.
NCT00223938 ·Status: TERMINATED ·Phase: PHASE4
-
A Study to Evaluate the Safety, Pharmacokinetics and Preliminary Efficacy of APG-5918.
NCT05773586 ·Status: RECRUITING ·Phase: PHASE1
-
A Double-Blind, Placebo-Controlled Study With Open-Label Follow-Up To Determine the Safety and Efficacy of Subcutaneous Doses of r-HuEPO in AIDS Patients With Anemia Induced by Their Disease and AZT Therapy
NCT00002073 ·Status: COMPLETED ·Phase: NA
-
Safety and Efficacy of Peginesatide for the Treatment of Anemia in Participants With Chronic Renal Failure Not on Dialysis
NCT00598442 ·Status: COMPLETED ·Phase: PHASE3
-
An Observational Study to Predict the Response of Erythropoietin Treatment in Participants With Cancer Related Anemia Receiving Chemotherapy
NCT01736215 ·Status: TERMINATED
-
4 Week Correction Study in Subjects With Anemia Associated With Chronic Kidney Disease Who Are Not Undergoing Dialysis
NCT01587898 ·Status: COMPLETED ·Phase: PHASE2